Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator

2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy

(2019) Jeffrey A. Towbin et al.   HEART RHYTHM

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

(2018) Mathew S. Maurer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis

(2018) Brian Lilleness et al.   BLOOD

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response

(2017) Martha Grogan et al.   HEART

Heart transplantation in cardiac amyloidosis

(2017) Matthew Sousa et al.   HEART FAILURE REVIEWS

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

(2017) Sana M. Al-Khatib et al.   HEART RHYTHM

99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses

(2013) Sabahat Bokhari et al.   Circulation-Cardiovascular Imaging

Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis

(2013) Brandon C. Varr et al.   HEART RHYTHM

Implantable Cardioverter Defibrillators in Patients with Cardiac Amyloidosis

(2013) GRACE LIN et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome

(2013) Jennifer H. Pinney et al.   Journal of the American Heart Association

Transthyretin (TTR) Cardiac Amyloidosis

(2012) Frederick L. Ruberg et al.   CIRCULATION

Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death

(2007) Arnt V. Kristen et al.   HEART RHYTHM